TCRX
Tscan Therapeutics Inc
0.349$
-4.1%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 74.7% | 71.4% | 68.4% | 79.9% | 78.8% | 78.9% | 76.6% | 74.1% | 71.8% | 68.7% | 65.7% | 60.9% | |
| 53.3% | 49.0% | 58.3% | 64.6% | 38.2% | 48.1% | 46.3% | 56.7% | 64.6% | 66.6% | 63.4% | 58.4% | |
| 73.9% | 70.6% | 67.6% | 79.4% | 77.9% | 78.2% | 75.6% | 73.0% | 70.3% | 66.6% | 63.4% | 58.4% | |
| 42.0% | 44.6% | 48.9% | 31.9% | 34.2% | 35.1% | 36.8% | 40.8% | 45.1% | 46.2% | 52.0% | 59.7% | |
| 11.4% | 11.0% | 13.1% | 10.3% | 8.2% | 9.7% | 9.0% | 10.5% | 11.1% | 8.2% | 9.9% | 18.1% | |
| 1.9% | 2.4% | 4.2% | 4.7% | 1.1% | 1.2% | 1.5% | 2.1% | 2.6% | 3.1% | 3.7% | 11.3% | |
| 1.1% | 0.9% | 0.9% | 0.8% | 1.0% | 1.2% | 1.5% | 1.5% | 2.4% | 0.5% | 1.1% | 1.8% | |
| 9.9% | 9.8% | 9.7% | 5.4% | 8.8% | 8.6% | 9.7% | 10.8% | 12.4% | 14.2% | 16.2% | 12.3% | |
| 58.0% | 55.4% | 51.1% | 68.1% | 65.8% | 64.9% | 63.2% | 59.2% | 54.9% | 53.8% | 48.0% | 40.3% | |
| -78.2% | -91.0% | -115.3% | -82.5% | -97.5% | -101.1% | -123.0% | -149.4% | -183.8% | -220.7% | -264.1% | -328.9% | |
| 32.5% | 34.8% | 39.4% | 30.3% | 34.1% | 32.5% | 39.0% | 43.5% | 49.5% | 56.8% | 64.3% | 75.8% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.